NEW ORLEANS -- Senate Finance Committee Chairman Sen. Chuck Grassley (R-IA) and Sen. Patrick Leahy (D-VT) introduced a bill Tuesday (Feb. 5) that they say would lower drug prices by blocking tactics brand-drug makers use to delay generic drug development by withholding drug samples. The Creating and Restoring Equal Access to Equivalent Samples Act was previously considered as an option for the brand-drug lobby to pay for lowering its share of Medicare Part D coverage gap costs, but there may...